Furthermore, overexpression and activation of BCMA are associated with the progression of myeloma in preclinical models and humans via canonical and non-canonical NF-kB pathways in charge of cell survival, growth, and metastasis [70]. This evidence concerns the gene NFKB1 and plasma cell myeloma.